BIO supports the U.S. Trade Representative’s (USTR) negotiations with the Government of Japan as an opportunity to grow U.S. exports and create U.S. jobs. We would strongly urge the U.S. government to build on the recent U.S.-Mexico-Canada agreement and that the agreement comprehensively addresses…

Last week BIO hosted embassy representatives from over 25 countries to debut a new report that highlights strategies, policies and best practices that have been successful in creating an environment in which biotechnology innovation can flourish around the world. The 5th edition of the Building…

A recently announced agreement between the New Jersey Economic Development Authority and the Israel Innovation Authority is a fitting testament to the theme for the upcoming BIO 2019 International Convention: It Starts with One.  In the intensely innovative biotechnology space, one meeting; one…

Next week the 73rd session of the United Nations General Assembly (UNGA) will convene in New York City. Among the many high-level meetings taking place, the UN will be evaluating progress of sustainable development goal (UN SDG) #3, “Ensuring Access to Healthcare,” with a specific focus on…

Venture capital investment in US biotech companies has skyrocketed as Chinese investors continue to fuel the US pharmaceutical startup sector. With over $1.4 billion invested by Chinese VC funds into private US biotechnology firms in Q1 2018 alone, the Chinese investment community represents a…

With the conclusion of the Winter Olympics earlier this year in South Korea, the pomp and circumstances in Pyeongchang were certainly emblematic of the country’s place as an influencer on the global stage. However, the country has focused on more than winter sports these last few years. They have…